Skip to Content

Pamidronate Disodium Injection

Last Updated: October 18, 2018
Status: Current

Products Affected - Description
    • Pamidronate disodium injection, Pfizer, 6 mg/mL, 10 mL vial, 1 count, NDC 61703-0325-18
    • Pamidronate disodium injection, Pfizer, 9 mg/mL, 10 mL vial, 1 count, NDC 61703-0326-18
Reason for the Shortage
    • Areva has pamidronate powder for injection available.
    • Mylan Institutional did not provide a reason for the shortage.
    • Pfizer has pamidronate on shortage due to manufacturing delays.
Available Products
    • Pamidronate disodium lyophilized powder for injection, Areva, 30 mg, vial, 1 count, NDC 59923-0601-10
    • Pamidronate disodium lyophilized powder for injection, Areva, 90 mg, vial, 1 count, NDC 59923-0603-10
    • Pamidronate disodium injection, Mylan Institutional, 3 mg/mL, 10 mL vial, 1 count, NDC 67457-0430-10
    • Pamidronate disodium injection, Mylan Institutional, 9 mg/mL, 10 mL vial, 1 count, NDC 67457-0446-10
    • Pamidronate disodium injection, Pfizer, 3 mg/mL, 10 mL vial, 1 count, NDC 61703-0324-18

Estimated Resupply Dates

    • Pfizer has pamidronate 9 mg/mL 10 mL vials available in limited supply. The 6 mg/mL 10 mL vials are on back order and the company estimates a release date of November 2018.

Updated

Updated October 18, 2018 by Michelle Wheeler, PharmD, Drug Information Specialist. Created March 6, 2018 by Michelle Wheeler, PharmD, Drug Information Specialist. Copyright 2018, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide